Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Axogen (AXGN) Return on Sales (2016 - 2025)

Historic Return on Sales for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to 0.01%.

  • Axogen's Return on Sales rose 500.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.06% for FY2024, which is 900.0% up from last year.
  • According to the latest figures from Q3 2025, Axogen's Return on Sales is 0.01%, which was up 500.0% from 0.0% recorded in Q2 2025.
  • Axogen's 5-year Return on Sales high stood at 0.01% for Q4 2024, and its period low was 0.38% during Q1 2022.
  • In the last 5 years, Axogen's Return on Sales had a median value of 0.14% in 2022 and averaged 0.14%.
  • As far as peak fluctuations go, Axogen's Return on Sales plummeted by -1800bps in 2021, and later surged by 1900bps in 2023.
  • Quarter analysis of 5 years shows Axogen's Return on Sales stood at 0.17% in 2021, then increased by 14bps to 0.14% in 2022, then rose by 23bps to 0.11% in 2023, then soared by 110bps to 0.01% in 2024, then dropped by -28bps to 0.01% in 2025.
  • Its Return on Sales was 0.01% in Q3 2025, compared to 0.0% in Q2 2025 and 0.07% in Q1 2025.